Non-arteritic anterior ischemic optic neuropathy (NAION) is a vision-related drug side effect commonly referred to as an "eye stroke". In this post, we focus on a new Ozempic eye stroke side effect rates study published in the March 2026 British Journal of Ophthalmology article, "Ischemic optic neuropathy with semaglutide: global observational … [Read more...]
NAION Ozempic Side-Effect Warning: Novo Nordisk Failure
We have written about the NAION Ozempic side-effect warning issue several times over the past year-and-a-half, and have repeatedly pointed out that non-arteritic anterior ischemic optic neuropathy, or NAION, is linked to semaglutide. Moreover, we noted that semaglutide is the active ingredient in the currently available Novo Nordisk semaglutide … [Read more...]
NAION Vision Loss With Ozempic, Wegovy, and Rybelsus: New Medical Evidence in 2026
Ozempic, Wegovy, and Rybelsus are semaglutide-containing drugs from Novo Nordisk. Starting in 2024, there have been reports of non-arteritic anterior ischemic optic neuropathy, or NAION, associated with these semaglutide-containing drugs. And there is new medical evidence in 2026 regarding NAION vision loss with Ozempic, Wegovy, and … [Read more...]
Semaglutide Deep Vein Thrombosis Case Information: 2026 Medical Journal Article
A 2026 medical journal article, which presented some semaglutide deep vein thrombosis case information, is of interest to us because Ozempic, Wegovy, and Rybelsus — three relatively new semaglutide-containing drugs — have been associated with a significantly increased risk of blood clots. We have been investigating Ozempic, Wegovy, and Rybelsus … [Read more...]
NAION Lawsuits Involving Ozempic and Mounjaro
As we have reported previously, vision loss due to Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) lawsuits involving Ozempic and Mounjaro are being filed. These NAION lawsuits seek legal compensation for the person suffering from this serious eye side effect injury. Ozempic NAION lawsuits are filed against Novo Nordisk. Mounjaro NAION … [Read more...]
Wegovy and Ozempic Eye Damage Compensation In Europe, Is US Next?
Drug injury lawsuits seeking compensation for patients with Wegovy and Ozempic eye damage side effects have been filed against the pharmaceutical company Novo Nordisk. These Wegovy and Ozempic eye damage lawsuits have received a boost, it seems, from some recent news out of Europe. From this November 21, 2025, article, "Denmark compensates … [Read more...]
GLP-1 RA Drug NAION Cases: Medical and Legal Updates October 2025
GLP-1 RA Drug NAION Cases: Possible Drug Injury Lawsuits We are investigating possible drug injury lawsuits where people using glucagon-like peptide-I receptor agonist (GLP-1 RA) drugs were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION), resulting in vision loss or blindness. Those GLP-1 RA drug NAION cases involve these … [Read more...]
Increased Risk of NAION Associated With Ozempic and Mounjaro
A 2025 medical study concluded that there is an increased risk of NAION associated with Ozempic and Mounjaro. In more detail, the researchers considered whether treatment with either Ozempic (semaglutide) or Mounjaro (tirzepatide) is associated with an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION) when compared to … [Read more...]
Semaglutide NAION Side Effect Can Be Part of a Vision Loss AION Diagnosis
The European Medicines Agency (EMA) confirmed the link between the active ingredient in Ozempic, semaglutide, and NAION (non-arteritic anterior ischemic optic neuropathy) in early June 2025. This drug regulator said further that a semaglutide NAION side effect warning would be added to the drug labels for the semaglutide-containing drugs Wegovy, … [Read more...]
Ozempic Vision Loss Lawsuits Against Novo Nordisk
Patients who are filing Ozempic vision loss lawsuits against Novo Nordisk had developed nonarteritic anterior ischemic optic neuropathy (NAION) while using Ozempic. These cases are product liability failure to warn lawsuits filed against the responsible drug company, Novo Nordisk, because the Ozempic drug label does not warn about NAION as a … [Read more...]